⌘K

Login Start Free

Home/Filings/4/A/0001144204-13-008393

4/A//SEC Filing

Damaj Bassam 4/A

Accession 0001144204-13-008393

CIK 0001411879other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 7:08 PM ET

Size

6.3 KB

Accession

0001144204-13-008393

Insider Transaction Report

Form 4/AAmended

Period: 2013-02-02

INNOVUS PHARMACEUTICALS, INC.INNV

DirectorPresident and CEO10% Owner

Transactions

Purchase
Common Stock
2013-02-02$0.48/sh+250,406$118,993→ 3,459,877 total

Holdings

Common Stock
(indirect: By IRA)
6,108
Common Stock
(indirect: By Spouse)
1,297,836

Footnotes (1)

[F1]On February 5, 2013, the Reporting Person filed a Form 4 reporting an incorrect amount of securities beneficially owned following the reported transaction.

Documents

1 file

4
v335184_4a.xml
OWNERSHIP DOCUMENT

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeother

Related Parties

1

filerCIK 0001478733

Filing Metadata

Form type: 4/A
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 7:08 PM ET
Size: 6.3 KB

View on SEC.gov